perftoran has been researched along with Primary Peritonitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullaev, IA | 3 |
| Arakelian, BV; Bagnenko, SF; Biriukova, EI; Mel'nikov, AS; Minnullin, RI; Rukhliada, NN | 1 |
| Magomedov, MA | 1 |
| Magomedov, MA; Yarema, IV | 1 |
| Grigor'ev, EV; Konysheva, TV; Lykova, OF; Moiseeva, LM; Romanova, TV; Zorin, NA | 1 |
| Askerkhanov, GR; Golubev, AM; Guseĭnov, AG; Moroz, VV; Zagirov, UZ | 1 |
1 trial(s) available for perftoran and Primary Peritonitis
| Article | Year |
|---|---|
[Application of ozonated perftoran in the treatment of spreaded peritonitis].
Topics: Adolescent; Adult; Aged; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Fluorocarbons; Humans; Injections, Intraperitoneal; Injections, Intravenous; Middle Aged; Oligopeptides; Ozone; Peritonitis; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
7 other study(ies) available for perftoran and Primary Peritonitis
| Article | Year |
|---|---|
[Impact of a combined application of ozonized perftoran and glutoxim on the immune status of the patients and the cytokines profile in extended peritonitis].
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Blood Substitutes; Case-Control Studies; Drug Therapy, Combination; Female; Fluorocarbons; Humans; Immunity, Innate; Immunologic Factors; Interleukin-4; Interleukin-8; Male; Middle Aged; Oligopeptides; Ozone; Peritonitis; Severity of Illness Index; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2014 |
[Effect on performance ozonized perftoran cytokine profile in generalized peritonitis].
Topics: Administration, Intravenous; Adult; Aged; Blood Substitutes; Female; Fluorocarbons; Humans; Interleukin-4; Interleukin-8; Male; Middle Aged; Monitoring, Immunologic; Oxidants, Photochemical; Ozone; Perioperative Care; Peritoneal Lavage; Peritonitis; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
[Possible correction of disturbed microcirculation in the gut in diffuse peritonitis of gynecological origin].
Topics: Adolescent; Adult; Blood Substitutes; Drug Administration Routes; Female; Fluorocarbons; Gynecologic Surgical Procedures; Humans; Intestines; Microcirculation; Middle Aged; Peritonitis; Retrospective Studies; Splanchnic Circulation; Stomach; Surgical Wound Infection; Treatment Outcome; Young Adult | 2009 |
[Local cellular regulation in formation of postoperative commissures in peritonitis].
Topics: Animals; Ascitic Fluid; Cell Division; Disease Models, Animal; Epithelium; Fluorocarbons; Intestines; Macrophages; Peristalsis; Peritonitis; Rats; Rats, Wistar; Serous Membrane | 2004 |
Experimental study of the use of Perftoran for preventing the formation of postoperative adhesions in peritonitis.
Topics: Animals; Cell Division; Exudates and Transudates; Fibroblasts; Fluorocarbons; Immunohistochemistry; Lymphocytes; Macrophages; Mast Cells; Mesoderm; Peritoneum; Peritonitis; Postoperative Complications; Rats; Rats, Wistar; Time Factors; Tissue Adhesions | 2003 |
Effect of perftoran on macroglobulin content in the plasma and peritoneal exudate of rats with acute exudative inflammation (peritonitis).
Topics: Acute Disease; alpha-Macroglobulins; Animals; Ascitic Fluid; Blood Substitutes; Exudates and Transudates; Female; Fluorocarbons; Male; Peritonitis; Rats; Silver Nitrate | 2004 |
[Intraperitoneal perfusion of perftoran in the treatment of patients with diffuse purulent peritonitis].
Topics: Bacteria; Blood Substitutes; Exudates and Transudates; Fluorocarbons; Humans; Infusions, Parenteral; Intraoperative Care; Peritoneal Cavity; Peritonitis; Phagocytosis; Suppuration | 2000 |